Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Completed NCT05515341

A DirEct to PatieNt Study in Chronic Pain

Conditions: Chronic Pain

Sex: All
Ages: 22 Years – N/A
Healthy volunteers: No
Enrollment: 73
Sponsor: Boston Scientific Corporation

Location: Boston Scientific Neuromodulation Valencia California

Summary

To compile real-world, direct from patient clinical outcomes and objective metrics in patients who have received or plan to receive a commercially approved interventional medical device therapy/procedure for chronic pain in routine clinical practice.

Eligibility Criteria

Key Inclusion Criteria: * Patient is planning to receive or has received a commercially approved interventional medical device therapy/procedure to treat chronic pain, ascertained from self-reporting * Age ≥ 22 years at time of eligibility screening, ascertained by self-reported age at time of eligibility screening * Proficient in written and spoken English, defined by self-reporting of comfort reading, writing and speaking English Key Exclusion Criteria: * Requires a legal representative to sign the ICF ascertained from self-reporting

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05515341). StuddyBuddy aggregates publicly available trial information.